bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) was up 38.1% on Thursday . The stock traded as high as $0.4093 and last traded at $0.2230. Approximately 12,401 shares changed hands during trading, an increase of 125% from the average daily volume of 5,518 shares. The stock had previously closed at $0.1615.
bioAffinity Technologies Stock Up 30.1%
The stock has a fifty day simple moving average of $0.18 and a 200-day simple moving average of $0.23.
About bioAffinity Technologies
bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.
In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.
See Also
- Five stocks we like better than bioAffinity Technologies
- Priced for a Pullback or More Gains? These 3 Stocks Are Testing the Limits
- These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories
- Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike
- MarketBeat Week in Review – 09/14 – 09/18
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
